"Truvada still has patent protection in the United States and in the rest of the world it is generic,"
Something not right about that.
This is kind of surprising it’s the first time I’ve found myself almost agreeing with her.
This time around, she's right. This might be a corollary to a broken clock is right twice a day.
Either that or the propoganda about her is only partly true.
Same boat here. Although I am doubtful I would agree with her solution to the problem.
Companies have to maintain some type of copyright protection on drugs, without it we won't see any investment in new ones.
The problem I see here is why are some countries having the copyright protection end so much sooner than the US. This places an unfair burden on the US population to pay for the R&D required for the products.
How to fix that? Ending protections here isn't a good option, maybe shorten them? It seems like an international treaty of some sort would be helpful where we can be sure the burden of payment is shared from all the benefit from these company's research.
I'd say we could put a tariff on the export, and then subsidize the cost, but that seems complicated, creating a government program, and there would be nothing to stop the companies from making the drug overseas if they aren't do so already.
(post is archived)